FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients

被引:10
|
作者
Georgina Turcott, Jenny [1 ]
Onate-Ocana, Luis F. [2 ]
Soca-Chafre, Giovanny [3 ]
Ramirez-Tirado, Laura-Alejandra [3 ]
Flores-Estrada, Diana [1 ]
Lucia Zatarain-Barron, Zyanya [1 ]
Arrieta, Oscar [1 ]
机构
[1] Natl Canc Inst Mexico INCan, Thorac Oncol Unit, Mexico City, DF, Mexico
[2] Natl Canc Inst Mexico INCan, Div Surg, Clin Res Div, Mexico City, DF, Mexico
[3] Natl Canc Inst Mexico INCan, Expt Oncol Lab, Mexico City, DF, Mexico
来源
关键词
QUALITY-OF-LIFE; NUTRITIONAL-STATUS; ASSOCIATION; VALIDATION; ANAMORELIN; PROGNOSIS; THERAPY; DISEASE; IMPACT;
D O I
10.1080/01635581.2018.1506488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer (LC) has a high rate of anorexia, which negatively affects quality-of-life and prognosis; however prevalence values may vary as per diagnostic test. There is no standard for anorexia diagnosis, currently the anorexia cachexia scale (A/CS) has been proposed as a tool for diagnosing anorexia with a consensus cutoff value of <= 24, nonetheless a validated cutoff value is required. The A/CS was evaluated in advanced Non-Small Cell Lung Cancer (NSCLC) patients to establish a cutoff value. The appetite item from the QLQ-C30 questionnaire and survival served as a standard reference. The cutoff value was associated with clinical and nutritional characteristics along with quality-of-life. Three hundred and twelve (312) NSCLC patients were evaluated. The mean A/CS value was 31 +/- 9 and the identified cutoff value was 32.5 (sensitivity: 80.3% and specificity: 85%). The proportion of anorexia accurately diagnosed with the cutoff value of 24 was 26%, while with 32 it was 50%. The A/CS cutoff value of 32 was associated with clinical parameters, nutritional consumption, and quality-of-life, and independently associated with overall survival. A score of <= 32 in the A/CS is proposed for anorexia diagnosis in order to identify patients at risk of complications involving malnutrition related to LC.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 50 条
  • [41] Impact of cachexia at diagnosis on radiotherapy utilization and survival in non-small cell lung cancer
    Lau, Steven
    Giap, Fantine
    Gannavarapu, Bhavani S.
    Iyengar, Puneeth
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26)
  • [42] Perception of subjective lived experiences of individuals with anorexia-cachexia in patients with advanced lung cancer
    Yennurajalingam, Sriram
    Mott, Frank
    Lu, Zhanni
    Urbauer, Diana
    Stanton, Penny
    Torres, Hilda
    Rantanen, Petra Ann
    Davis, Sara
    Dev, Rony
    Hui, David
    Bruera, Eduardo
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2023, 10
  • [43] Efficacy of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia and modified Glasgow Prognostic Score (mGPS) of 2: Pooled analysis of two phase 3 trials
    Kaasa, S.
    Laird, B.
    Fallon, M.
    McMillan, D.
    Skipworth, R.
    Currow, D.
    Giorgino, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [44] Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer
    Fujii, Hironori
    Araki, Ayumu
    Iihara, Hirotoshi
    Kaito, Daizo
    Hirose, Chiemi
    Kinomura, Motohiko
    Yamazaki, Mizuki
    Endo, Junki
    Inui, Toshiya
    Yanase, Komei
    Sasaki, Yuka
    Gomyo, Takenobu
    Sakai, Chizuru
    Kawae, Daisuke
    Kitamura, Yu
    Fukui, Masachika
    Kobayashi, Ryo
    Ohno, Yasushi
    Suzuki, Akio
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (04)
  • [45] Chemotherapy in patients with advanced non-small cell lung cancer
    Price, A
    CLINICAL ONCOLOGY, 2001, 13 (06) : 480 - 482
  • [46] Advanced non-small cell lung cancer in elderly patients
    Quoix, Elisabeth
    BREATHE, 2012, 9 (01) : 27 - 34
  • [47] Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
    Koukidou, Sofia
    Charpidou, Andriani
    Vassos, Dimitrios
    Grapsa, Dimitra
    Ampelioti, Sevasti
    Dimakou, Ekaterini
    Bakakos, Petros
    Poulakou, Garyphallia
    Syrigos, Konstantinos
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [48] The Value of Hope: Patients' and Physicians' Preferences for Survival in Advanced Non-Small Cell Lung Cancer
    Hauber, Brett
    Penrod, John R.
    Gebben, David
    Musallam, Lina
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 2093 - 2104
  • [49] Effects of Serum Leptin and Resistin Levels on Cancer Cachexia in Patients With Advanced-Stage Non-Small Cell Lung Cancer
    Demiray, Gokcen
    Degirmencioglu, Serkan
    Ugurlu, Erhan
    Yaren, Arzu
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2017, 11
  • [50] ROMANA 3: A safety extension study of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with cachexia
    Currow, D.
    Temel, J.
    Fearon, K.
    Friend, J.
    Yan, Y.
    Abernethy, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S239 - S239